Seaweed as medicine? wakame put to the test against kidney disease

NCT ID NCT07729683

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether eating 5 grams of wakame seaweed daily for three months can lower levels of harmful AGEs in the blood of people with stage III chronic kidney disease. AGEs are compounds that may speed up kidney damage. The study includes 30 adults who will add the seaweed to their meals using recipes from a Michelin-starred chef. The goal is to see if this simple dietary change can offer extra kidney protection on top of standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a daily 5-gram dose of wakame (Undaria pinnatifida) seaweed flakes
What this could lead to
If it works, this could offer a simple, sustainable dietary addition to help slow the progression of chronic kidney disease.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The effect on kidney function is uncertain, and dietary changes can be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Groupe Hospitalier de La Rochelle Ré Aunis

    RECRUITING

    La Rochelle, 17000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.